Certified by Founder Lodge
Ampersand Biomedicines
United States - Boston, Massachusetts
START UP
1 Disclosed Funding Rounds $65,000,000
0 Participating Investments
-
Founded date
2021
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Ampersand Biomedicines enables a new way of designing programmable medicines that work precisely where needed in the body and nowhere else. The company’s state-of-the-art computationally powe
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| March, 26 ,2025 | Series B | $65,000,000 |
Eli Lilly and Company
Flagship Pioneering
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Assort Health | $26,000,000 | (Apr 18, 2025)
Nyobolt | $30,000,000 | (Apr 18, 2025)
Pillar Security | $9,000,000 | (Apr 18, 2025)
Meadow | $14,000,000 | (Apr 18, 2025)
Graze Social | $1,000,000 | (Apr 18, 2025)
